Yutao Lou

Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS/MS and its application in the clinical determination in patients with tumors associated with overactive bladder

Yutao Lou, Mengting Cheng, Qin Cao et al. · Journal of Pharmaceutical and Biomedical Analysis · 2023 · 97 citations

Medicine, Oncology, Pharmacology +6

Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats

Yutao Lou, Feifeng Song, Mengting Cheng et al. · PeerJ · 2023 · 54 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

The mechanism of action of <i>Botrychium (Thunb.) Sw.</i> for prevention of idiopathic pulmonary fibrosis based on 1H-NMR-based metabolomics

Yutao Lou, Xiaozhou Zou, Zongfu Pan et al. · Journal of Pharmacy and Pharmacology · 2024 · 49 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Simultaneous quantification of donafenib, sorafenib, and their N-oxide metabolites in rat plasma using a HPLC-MS/MS method

Yutao Lou, Zhiyong Sun, Yitao Chai et al. · Journal of Chromatography B · 2023 · 18 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

A single-dose, randomized, open-label, four-period, crossover equivalence trial comparing the clinical similarity of the proposed biosimilar rupatadine fumarate to reference Wystamm® in healthy Chinese subjects

Sisi Lin, Yutao Lou, Rui Hao et al. · Frontiers in Pharmacology · 2024 · 18 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15